Edition:
United Kingdom

Sellas Life Sciences Group Inc (SLS.OQ)

SLS.OQ on NASDAQ Stock Exchange Capital Market

0.15USD
4:18pm BST
Change (% chg)

$-0.00 (-1.01%)
Prev Close
$0.15
Open
$0.15
Day's High
$0.15
Day's Low
$0.15
Volume
445,945
Avg. Vol
3,617,655
52-wk High
$2.46
52-wk Low
$0.10

About

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunothera... (more)

Overall

Beta: 1.36
Market Cap(Mil.): $20.43
Shares Outstanding(Mil.): 127.69
Dividend: --
Yield (%): --

Financials

  SLS.OQ Industry Sector
P/E (TTM): -- 29.73 33.85
EPS (TTM): -2.63 -- --
ROI: -287.20 13.04 12.69
ROE: -4,444.12 14.12 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates